Cost-effectiveness of the introduction of specialized oral care with laser therapy in hematopoietic stem cell transplantation

Hematological Oncology

Volumn 32, Issue 1, 2014, Pages 31-39

  Bezinelli, Letícia Mello ^a,b   de Paula Eduardo, Fernanda ^a   da Graça Lopes, Roberta Marques ^a   Biazevic, Maria Gabriela Haye ^b   de Paula Eduardo, Carlos ^b   Correa, Luciana ^b   Hamerschlak, Nelson ^a   Michel Crosato, Edgard ^b  

^a HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Hematopoietic stem cell transplantation; Low level laser therapy; Oral hygiene; Oral mucositis

Indexed keywords

ACICLOVIR; ALPHA TOCOPHEROL; COTRIMOXAZOLE; FLUCONAZOLE; LEVOFLOXACIN; MOUTHWASH; NYSTATIN; OPIATE; THEOBROMA OIL; VALACICLOVIR;

ADULT; ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; FEMALE; FEVER; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITAL CHARGE; HOSPITALIZATION COST; HUMAN; INFECTION PREVENTION; LOW LEVEL LASER THERAPY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MOUTH EXAMINATION; MOUTH HYGIENE; MOUTH PAIN; ORAL MUCOSITIS; PARENTERAL NUTRITION; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; TOOTHBRUSH; XEROSTOMIA;

HEMATOPOIETIC STEM CELL TRANSPLANTATION; LOW-LEVEL LASER THERAPY; ORAL HYGIENE; ORAL MUCOSITIS;

ADULT; AGED; ALLOGRAFTS; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; ANTIFUNGAL AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAZIL; CASE-CONTROL STUDIES; COST-BENEFIT ANALYSIS; DENTISTS; DRUG COSTS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITAL COSTS; HOSPITALIZATION; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; LASER THERAPY, LOW-LEVEL; MALE; MIDDLE AGED; MYELOABLATIVE AGONISTS; NARCOTICS; OPPORTUNISTIC INFECTIONS; ORAL HYGIENE; PARENTERAL NUTRITION; PATIENT CARE TEAM; RETROSPECTIVE STUDIES; SELF CARE; STOMATITIS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS;

EID: 84895549502     PISSN: 02780232     EISSN: 10991069     Source Type: Journal    
DOI: 10.1002/hon.2050     Document Type: Article

References (17)

1. Keefe DM, Schubert MM, Elting LS, et al. Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 2007; 109(5): 820-831.
2. Sonis ST, Oster G, Fuchs H, et al. Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol 2001; 19(8): 2201-2205.
3. Sonis ST. Mucositis: The impact, biology and therapeutic opportunities of oral mucositis. Oral Oncol 2009; 45(12): 1015-1020.
4. Soga Y, Sugiura Y, Takahashi K, et al. Progress of oral care and reduction of oral mucositis-a pilot study in a hematopoietic stem cell transplantation ward. Support Care Cancer 2010; 19(2): 303-307.
5. Santos PS, Coracin FL, Barros JC, Dulley FL, Nunes FD, Magalhães MG. Impact of oral care prior to HSCT on the severity and clinical outcomes of oral mucositis. Clin Transplant 2011; 25(2): 325-328.
6. Bjordal JM, Bensadoun RJ, Tunèr J, Frigo L, Gjerde K, Lopes-Martins RA. A systematic review with meta-analysis of the effect of low-level laser therapy (LLLT) in cancer therapy-induced oral mucositis. Support Care Cancer 2011; 19(8): 1069-1077.
7. Schubert MM, Eduardo FP, Guthrie KA, et al. A phase III randomized double-blind placebo-controlled clinical trial to determine the efficacy of low level laser therapy for the prevention of oral mucositis in patients undergoing hematopoietic cell transplantation. Support Care Cancer 2007; 15(10): 1145-1154.
8. Antunes HS, de Azevedo AM, da Silva Bouzas LF, et al. Low-power laser in the prevention of induced oral mucositis in bone marrow transplantation patients: a randomized trial. Blood 2007; 109(5): 2250-2255.
9. Khouri VY, Stracieri AB, Rodrigues MC, et al. Use of therapeutic laser for prevention and treatment of oral mucositis. Braz Dent J 2009; 20(3): 215-220.
10. Chor A, Torres SR, Maiolino A, Nucci M. Low-power laser to prevent oral mucositis in autologous hematopoietic stem cell transplantation. Eur J Haematol 2010; 84(2): 178-179.
11. o 48:16-7].
12. Eduardo FP, Bezinelli L, Luiz AC, Correa L, Vogel C, Eduardo CP. Severity of oral mucositis in patients undergoing hematopoietic cell transplantation and an oral laser phototherapy protocol: a survey of 30 patients. Photomed Laser Surg 2009; 27(1): 137-144.
13. Barasch A, Peterson DE. Risk factors for ulcerative oral mucositis in cancer patients: unanswered questions. Oral Oncol 2003; 39(2): 91-100.
14. Kashiwazaki H, Matsushita T, Sugita J, et al. Professional oral health care reduces oral mucositis and febrile neutropenia in patients treated with allogeneic bone marrow transplantation. Support Care Cancer 2012; 20(2): 367-373.
15. Wardley AM, Jayson GC, Swindell R, et al. Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue. Br J Haematol 2000; 110(2): 292-299.
16. Vagliano L, Feraut C, Gobetto G, et al. Incidence and severity of oral mucositis in patients undergoing haematopoietic SCT-results of a multicentre study. Bone Marrow Transplant 2011; 46(5): 727-732.
17. Sugita J, Matsushita T, Kashiwazaki H, et al. Efficacy of folinic acid in preventing oral mucositis in allogeneic hematopoietic stem cell transplant patients receiving MTX as prophylaxis for GVHD. Bone Marrow Transplant 2012; 47(2): 258-264.